Le Lézard
Classified in: Business
Subject: FNC

GenTech "Calibrating" for Continued Growth and Success


ARCADE, N.Y., Sept. 30, 2020 /PRNewswire/ -- Lakelet Capital LLC ("Lakelet") is pleased to announce its investment in GenTech Scientific LLC ("GenTech" or the "Company"), a refurbisher, re-seller, and servicer of high-quality analytical instrumentation. Lakelet's investment will support the buyout and provide growth capital to enhance operations, extend geography, and expand solution offerings.

GenTech has been providing scientists, researchers, and lab technicians with high quality mass spectrometers, gas chromatographs, high-powered liquid chromatographs, and consumables for over 25 years. GenTech serves customers in diverse industries including testing & diagnostics, agriculture, flavor & fragrance, oil & gas, academia, healthcare, pharmaceuticals, and cannabis.

Lakelet's Managing Partner, Randy Bianchi, commented, "Lakelet has been seeking opportunities in the precision instrumentation market segment and was thrilled to develop a relationship with GenTech founder and industry pioneer, Clair Bragg. Together we quickly identified a mutual fit and a common vision to continue GenTech's legacy and path to growth."

As part of the investment strategy, Lakelet was pleased to recruit Michael Lippa as the new GenTech CEO, most recently, the COO of a leading global manufacturer and a Six Sigma Black Belt.  

Michael Lippa, GenTech's CEO, said, "I am thrilled for the opportunity to work collaboratively with the GenTech team, and to help lead GenTech's next stage of growth.  As a former client of GenTech, at Multisorb, having purchased instruments for our manufacturing lab, I can speak first-hand to the quality of the products, services and GenTech's value proposition. After meeting the team, it was clear why GenTech has been celebrating such tenure, success, and reputation: they are knowledgeable about the business, care deeply about client satisfaction, and are committed to excellence."

About GenTech Scientific LLC
GenTech is a leading refurbisher, re-seller, and servicer of high quality analytical instrumentation and consumables to laboratories. GenTech Scientific is located in Arcade, NY.

About Lakelet Capital LLC
Lakelet Capital is a Buffalo-based private equity firm investing in private companies for growth or succession. Lakelet takes a long-term investment approach helping companies go from "legacy to longevity".

Contact:  Mike Lippa, GenTech
Phone: 585- 492-1068
Email: [email protected]

Contact:  Randy Bianchi, Lakelet Capital
Phone: 716-277-0502
Email: [email protected]

SOURCE Lakelet Capital


These press releases may also interest you

at 08:54
Sekisui House, Ltd. ("Sekisui House") (TSE:1928), through SH Residential Holdings, LLC, a subsidiary of Sekisui House US Holdings, LLC, its U.S. business controlling company (the "Sekisui House Group"), today announced that it has completed its...

at 08:41
Stratus Vineyards, a leader in innovative and sustainable winemaking, is proud to announce the release of a new, super-premium wine in bottles that are being used for the second time.  They believe this pioneering project marks the first time a North...

at 08:40
PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") , a biotechnology company focused on the research, development, and manufacturing of LaNeotm MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that, further...

at 08:36
Sila Services, LLC is pleased to announce its acquisition of T-Mark Plumbing, Heating, Cooling & Electric, Western New York's leading home services company. Founded in Buffalo in 1998, T-Mark's reputation for reliability, responsiveness, and...

at 08:35
Pagaya Technologies intends to announce its first quarter 2024 earnings on May 9, 2024. A conference call to discuss those earnings will be held on the same day at 8:30 a.m. ET / 3:30 p.m. IDT. Details to register for the live webcast presentation...

at 08:35
Outset Medical, Inc. ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2024 after the...



News published on and distributed by: